TARA icon

Protara Therapeutics

59 hedge funds and large institutions have $124M invested in Protara Therapeutics in 2025 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 24 increasing their positions, 12 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

8.24% less ownership

Funds ownership: 86.45%78.22% (-8.2%)

11% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 9

21% less capital invested

Capital invested by funds: $157M → $124M (-$32.8M)

Holders
59
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.21M
Puts
$478K
Net Calls
Net Calls Change

Top Buyers

1 +$6.96M
2 +$3.66M
3 +$2.19M
4
UBS Group
UBS Group
Switzerland
+$2.08M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.04M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$17.4M
2
$14.5M
3
$7.43M
4
$7.37M
5
$7.1M
6
$6.83M
7
$6.45M
8
$5.96M
9
$5.45M
10
$5.07M
11
$4.64M
12
$3.63M
13
$3.41M
14
$2.71M
15
$2.69M
16
$2.42M
17
$2.29M
18
$1.76M
19
$1.53M
20
$1.48M
21
$1.23M
22
$1.17M
23
$1.16M
24
$1M
25
$977K